StonvexLoading…
StonvexStonvexStonvexCore line items from UTZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $361.30M | $1.44B | $1.10B | $718.80M |
Operating Income | $7.80M | $19.50M | $15.40M | $12.10M |
Net Income | $-1.70M | $800.00K | $3.30M | $18.00M |
EPS (Diluted) | $-0.02 | $0.01 | $0.04 | $0.21 |
Total Assets | $2.79B | $2.79B | $2.78B | $2.84B |
Total Liabilities | $1.45B | $1.45B | $1.41B | $1.46B |
Cash & Equivalents | $73.70M | $120.40M | $57.70M | $54.60M |
Free Cash Flow OCF − CapEx | $-26.00M | $9.40M | $-41.90M | $-69.60M |
Shares Outstanding | 88.35M | 87.77M | 87.80M | 87.60M |